First Wave’s Adrulipase Disappoints In Third Phase II CF EPI Trial Despite New Formulation

Stock Down By 39%

 
• By Ayisha Sharma
  
graphic image of fat cells
Adrulipase Is Designed To Break Up Fat Molecules In The Digestive Tract • Source: Shutterstock

More from Clinical Trials

More from R&D